BillionToOne logo

BillionToOneThe genetic testing platform detecting and measuring disease.

BillionToOne has developed a DNA molecular counter that increases the cell-free DNA diagnostics resolution by over 1,000 fold, which unlocks transformative improvements in prenatal screening and liquid biopsy for cancers. Unity Screen, BillionToOne's commercially available non-invasive prenatal test (NIPT), is the only NIPT that can assess fetal risk for both recessive conditions and aneuploidies from maternal blood. UNITY Screen continues to grow exponentially and is on its path to becoming the next standard-of-care, with an increasing number of publications showing its accuracy and advantages over other screening methods. We have also recently used our molecular counting technology to develop liquid biopsy tests, which have the potential to completely transform oncology care.

2016-01-21
Active
Growth
S17
300
Healthcare
United States of AmericaAmerica / CanadaRemotePartly Remote
BillionToOne screenshot
More About BillionToOne

BillionToOne: Precision Disease Detection

Revolutionizing Molecular Diagnostics

BillionToOne is at the forefront of molecular diagnostics, leveraging proprietary technology to detect and quantify disease at the single base-pair level. Our mission is to make molecular testing more accurate, efficient, and accessible, ultimately improving patient outcomes.

Key Features

  • Quantitative Counting Templates (QCTs™): Detect and measure tiny and sparse disease-related DNA fragments at the single base-pair level.
  • UNITY Screen™: Comprehensive prenatal screening for recessive conditions and aneuploidies using maternal blood.
  • Northstar Select™ and Northstar Response™: Oncology solutions for therapy selection and monitoring treatment efficacy.

Use Cases

  • Prenatal Screening: Assess fetal risk for recessive conditions and aneuploidies from a simple maternal blood draw.
  • Oncology Testing: Determine the most appropriate first-line therapy and monitor treatment response in cancer patients.

Pricing

BillionToOne offers competitive pricing tailored to the needs of healthcare providers and patients. Contact us for detailed pricing information and to learn about our flexible payment options.

Teams

Our team comprises engineers, scientists, and industry experts dedicated to advancing molecular diagnostics. We value growth, equality, and cross-departmental teamwork, fostering a culture of innovation and collaboration. Join us in our mission to improve healthcare for all.

Explore our open positions and become part of a team that is making a significant impact in the field of molecular diagnostics.